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Methods: Opticin was extracted from normal and OA human cartilage
using guanidinium chloride (4M) extraction and examined by Western
blotting. Human MMP 1, -2, -3, -7, -8, -9 and ADAMTS-4, -5 proteolytic
activities on opticin were analyzed on normal and OA cartilage extracts
incubated for 0−24 hours
Results: One of the emerging observations was that all MMPs and
ADAMTS tested, except MMP-9, cleaved opticin in both normal and OA
specimens. Interestingly, MMP-7 and -8 were the most effective, and
degradation occurred as early as 15 minutes of incubation. At which
time, degradation was almost complete for MMP-7, suggesting that this
molecule is a preferential substrate for this enzyme. In contrast, MMP-1
was the least effective and degradation was noted after an incubation
of 16 hours. The others enzymes showed degradation starting at about
2 hours. The degradation pattern, except for MMP-7 in which degradation
appeared independent of the specimen types, was different between
normal and OA. In general, the degradation pattern was slower in normal
than in OA specimens, reﬂecting an increased sensitivity of opticin to
degradation when the cartilage was damaged. Fragments were also
detected, but the number and size differed depending on the protease.
This indicates different digestion sites among the proteases. Surprisingly,
MMP-1 and -2 generated different opticin degradation fragments when
normal were compared to OA specimens. The different opticin protease
cleavage sites are currently under study.
Conclusions: We showed, for the ﬁrst time, the ability of different MMP
and ADAMTS to degrade opticin. As opticin may contribute to the struc-
tural stability of cartilage matrix, its cleavage may predispose cartilage to
degradation. In vivo identiﬁcation of the cleavage products may assist in
an early detection of OA cartilage matrix degeneration.
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Purpose: Diabetes mellitus is an important risk factor for osteoarthritis
(OA), but the mechanisms involved are largely unknown. In chondrocytes,
glucose is essential for energy production and the synthesis of matrix
components. Diabetic patients can experience extended episodes of
hyper- and hypoglycemia that are likely to affect the delivery of glucose
to the synovial joint and its availability to chondrocytes. Glucose transport
is the limiting step in glucose utilization and the facilitative glucose
transporter-1 (GLUT-1) is the major glucose transporter in chondrocytes.
This study aimed at comparing the ability of normal and OA chondrocytes
to regulate glucose uptake and GLUT-1 levels in response to high and
low extracellular glucose concentrations.
Methods: Normal human chondrocytes were isolated from the femoral
condyles of multi-organ donors. OA chondrocytes were isolated from
the cartilage obtained from patients undergoing total knee replacement
surgery. Serum-starved subconﬂuent chondrocyte cultures were incu-
bated in media with 0, 10 or 30mM glucose. Total GLUT-1 content
was evaluated by western blotting. Glucose transport was determined
by measuring the uptake of non-metabolizable 2-Deoxy-D-2-[2,6-3H] glu-
cose into chondrocytes for 30 minutes at 37ºC. GLUT-1 gene expression
was measured by Real Time PCR. To determine the role of lysosomes in
GLUT-1 regulation, chondrocyte cultures in regular (10mM glucose) or
high glucose (30mM) medium were treated with 20 mM chloroquine, an
inhibitor of lysosome function, for the last 6 hours of an 18 hour incubation
period.
Results: Treatment of normal chondrocytes with 30mM glucose for
either 18 or 48 hours signiﬁcantly decreased 2-Deoxy-D-Glucose uptake
(75.4±3.6% and 71.5±2.6%, respectively) and GLUT-1 protein levels
(68.2±9.1% and 64.6±6.0%, respectively) relative to cells cultured under
10mM glucose. In contrast, 2-Deoxy-D-Glucose uptake (102.5±3.1%)
and GLUT-1 levels (116.51±9.6%) remained unchanged in OA chon-
drocytes cultured for 48 hours in the high glucose medium. GLUT-1
mRNA levels, either in normal or OA chondrocytes, were not affected by
treatment with high glucose for 6, 12 or 24 h. Similarly to normal cells, OA
chondrocytes responded to glucose deprivation by increasing 2-Deoxy-
D-Glucose uptake (128±2%) and total GLUT-1 levels (137.8±8.6%).
Treatment with 20mM chloroquine signiﬁcantly increased total GLUT-1
protein in normal chondrocytes, both under regular (10mM) and high
glucose conditions.
Conclusions: OA chondrocytes are capable of upregulating the net rate
of glucose transport and GLUT-1 protein when deprived of glucose,
suggesting that they are capable of sensing and adjusting to low extracel-
lular glucose concentrations. However, unlike normal chondrocytes, OA
chondrocytes fail to downregulate glucose transport and GLUT-1 protein
under high glucose concentrations. This may lead to an abnormally high
intracellular glucose concentration, which in turn may lead to altered cell
function and the formation of glycation end products during extended
periods of hyperglycemia in vivo. The lack of signiﬁcant differences in
GLUT-1 mRNA, together with GLUT-1 accumulation in normal chon-
drocytes exposed to chloroquine, indicate that GLUT-1 downregulation
depends on lysosomal degradation. The role of lysosomal function in
the inability of OA chondrocytes to adequately respond to high glucose
remains to be elucidated.
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Purpose: Previously we have shown that cartilage chondrocyte alkaline
phosphatase (ALP) is up regulated in active osteoarthritis (OA) and down
regulated in calcium pyrophosphate dihydrate (CPPD) crystal deposition
disease. Furthermore, CPPD crystals can be dissolved by the action
of ALP provided that the enzyme is bound to the crystals. Modulating
the action of ALP would then suggest a possible route to affect these
conditions. To obtain a better understanding of the action of ALP on
CPPD crystal dissolution, we investigated inhibition by endogenous amino
acids on ALP substrates; organic phosphate, inorganic pyrophosphate,
and CPPD crystals.
Methods: CPPD crystals were made using established methods de-
veloped in our laboratory. The phosphatase (Piase), pyrophosphate
hydrolase (PPiase), and CPPD crystal dissolution activities of tissue
nonspeciﬁc alkaline phosphatase (TNAP) were investigated in vitro using
cysteine and mercaptopyruvate (MPA) as inhibitors of Bovine kidney
ALP. Enzyme activity was determined by measuring liberated inorganic
phosphate (Pi) from p-Nitrophenyl phosphate (pNPP), or Sodium py-
rophosphate, at speciﬁc times and conditions. CPPD crystal dissolution
was assessed by measuring [Pi] liberated into solution in the presence of
TNAP. To assess enzyme inhibition, kinetics parameters such as Vmax
and Km, were determined and speciﬁc activities were calculated from Ini-
tial Velocity, Eadie-Hofstee, Simple, Dixon, and Secondary plots. Assays
were run under physiologic conditions with Tris-HCl buffer, pH=7.4 and at
37ºC. TNAP was at 200U/L and the buffer was supplemented with 1mM
Ca++ and 1mM Mg++. Enzyme activity was expressed as nmoles Pi/unit
TNAP/minute.
Results: At physiologic concentration, cysteine had no inhibitory effect
on any activity of TNAP. At 10× physiologic concentration, cysteine
signiﬁcantly inhibited phosphatase and pyrophosphate hydrolase activity
but did not inhibit CPPD crystal dissolution. MPA and cysteine together
inhibited TNAP’s phosphatase and pyrophosphate hydrolase activity at
physiologic concentration while CPPD crystal dissolution was only slightly
inhibited. When the two inhibitors were increased to 10x physiologic
concentration, all enzyme activity decreased signiﬁcantly as is shown
in the summary table.
Effect of Amino Acid Inhibitors on Enzyme Activity
Enzyme Substrate Inhibitors
Concentration nmolesPi/unit ALP/Minute
× physiological Cysteine Cysteine + MPA
% %
ALP (Piase) pNPP 2000uM 0 29 100 28 100
1× 28 98 8 29
10× 11 37 4 14
ALP (PPiase) Pyrophosphate 2000 uM 0 27 100 55 100
1× 30 110 21 39
10× 18 66 19 34
ALP CPPD 50ug/mL 0 0.46 100 0.26 100
1× 0.49 107 0.23 88
10× 0.43 93 0.10 38
Conclusions: The amino acids cysteine and MPA together are capable of
inhibiting phosphatase and pyrophosphate hydrolase activity of TNAP at
